Laramie M. Gaster

SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7

Gareth J. Inman, Francisco José Nicolás, James F. Callahan et al. · Molecular Pharmacology · 2002 · 1.7K citations

Life Sciences, Molecular Biology, Pharmacology +13

Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

Nicholas J. Laping, Eugene T. Grygielko, Anil Mathur et al. · Molecular Pharmacology · 2002 · 650 citations

Life Sciences, Molecular Biology, Pharmacology +16

Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)

James F. Callahan, Joelle L. Burgess, James A. Fornwald et al. · Journal of Medicinal Chemistry · 2002 · 309 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

SB-216641 and BRL-15572 – compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors

Gary Price, Melanie J. Burton, L. J. Collin et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1997 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

SB‐224289–a novel selective (human) 5‐HT_1B receptor antagonist with negative intrinsic activity

Julie V. Selkirk, Claire M. Scott, M Ho et al. · British Journal of Pharmacology · 1998 · 125 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17